The Alzheimer's therapeutic Lecanemab induces an amyloid-clearing program in microglia
Giulia Albertini, Magdalena Zielonka, Cuypers Marie-Lynn…·Bart De Strooper
This study shows Lecanemab reduces amyloid pathology by activating microglia through Fc fragment engagement, enhancing phagocytosis and lysosomal degradation.